NeuroBo Pharma'a IND Application For DA-1726 Gets FDA Clearance

NeuroBo Pharmaceuticals, Inc. (NRBO) announced on Thursday that the FDA has approved its Investigational New Drug or IND application for DA-1726, a new dual oxyntomodulin analog agonist.

Related Keywords

,Neurobo Pharmaceuticals Inc ,Nasdaq ,Neurobo Pharmaceuticals ,Investigational New Drug ,Fda ,End ,Neurobo Pharma ,Vrbo ,A 1726 ,